International external quality assessment for SARS-CoV-2 molecular detection and survey on clinical laboratory preparedness during the COVID-19 pandemic, April/May 2020
International external quality assessment for SARS-CoV-2 molecular detection and survey on clinical laboratory preparedness during the COVID-19 pandemic, April/May 2020
复制标题
DOI：
10.2807/1560-7917.es.2020.25.27.2001223
复制
发表时间：
2020-07-09
期刊：
影响因子：
19
通讯作者：
Ieven, Margareta
中科院分区：
文献类型：
--
作者：
Matheeussen, Veerle;Corman, Victor M.;Ieven, Margareta
为控制当前的冠状病毒病（COVID-19）爆发，必须在实验室做好准备，提供有质量保证的诊断检测。我们使用灭活的严重急性呼吸综合征冠状病毒2型（SARS-CoV-2）样本进行了一项外部质量评估研究，以支持临床实验室进行分子检测的能力验证。为了分析SARS-CoV-2检测性能，我们使用了为欧盟项目RECOVER开发的在线问卷，以评估临床诊断实验室的分子检测能力。
Laboratory preparedness with quality-assured diagnostic assays is essential for controlling the current coronavirus disease (COVID-19) outbreak. We conducted an external quality assessment study with inactivated severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) samples to support clinical laboratories with a proficiency testing option for molecular assays. To analyse SARS-CoV-2 testing performance, we used an online questionnaire developed for the European Union project RECOVER to assess molecular testing capacities in clinical diagnostic laboratories.